AGTR1 and COVID-19: Several FX containing seaweeds might be able to reduce the degree of angiotensin-converting enzyme (ACE)/angiotensin II (AngII)/angiotensin receptor II type 1 (ATR1) axis dominance by inhibiting ACE in COVID-19 patients (Tamama, 2020).